IRON - Disc Medicine, Inc.

QQQ $ 629.16 $ 3.02 (0.48 %)

DIA $ 475.58 $ 0.66 (0.14 %)

SPY $ 681.80 $ 2.23 (0.33 %)

TLT $ 90.21 $ -0.27 (-0.3 %)

GLD $ 368.20 $ -2.01 (-0.54 %)

Previous Close

$ 86.22

Open

$ 85.88

Bid

$ 83.57 x 10

Ask

$ 90.01 x 59

Day's Range

$ 84.52 - $ 87.00

52 Week Range

$ 30.82 - $ 95.95

Volume

252,817

Average Volume

Market Cap

Beta (5Y Monthly)

$ 0.90

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-07-2025	06-30-2025	10-Q
2	05-07-2025	03-31-2025	10-Q
3	02-27-2025	01-01-1970	10-K
4	11-12-2024	09-30-2024	10-Q
5	08-08-2024	06-30-2024	10-Q
6	05-09-2024	03-31-2024	10-Q
7	03-21-2024	12-31-2023	10-K
8	11-09-2023	09-30-2023	10-Q
9	08-11-2023	06-30-2023	10-Q
10	05-15-2023	03-31-2023	10-Q
11	03-31-2023	12-31-2022	10-K
12	11-10-2022	09-30-2022	10-Q
13	08-11-2022	06-30-2022	10-Q
14	05-06-2022	03-31-2022	10-Q
15	03-10-2022	12-31-2021	10-K
16	11-15-2021	09-30-2021	10-Q
17	08-12-2021	06-30-2021	10-Q
18	05-13-2021	03-31-2021	10-Q
19	03-29-2021	12-31-2020	10-K
20	11-12-2020	09-30-2020	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Morgan Stanley Maintains Overweight on Dis...
10/30/2025 18:04:10

Morgan Stanley analyst Sean Laaman maintains Disc Medicine (NASDAQ:IRON) with a Overweight and raises the price target from ...

Disc Medicine Prices $250M Upsized Public ...
10/21/2025 06:20:57

Disc Medicine Accelerates Late-Stage Trial...
10/20/2025 10:35:47

Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commer...

Raymond James Maintains Strong Buy on Disc...
10/17/2025 16:20:18

Raymond James analyst Michael Freeman maintains Disc Medicine (NASDAQ:IRON) with a Strong Buy and raises the price target fr...

gold-falls-1-slb-posts-better-than-expected-q3-earnings

Gold Falls 1%; SLB Posts Better-Than-Expec...
10/17/2025 16:17:56

revolution-medicines-disc-medicine-american-express-and-other-big-stocks-moving-higher-on-friday

Revolution Medicines, Disc Medicine, Ameri...
10/17/2025 16:02:18

Cantor Fitzgerald Maintains Overweight on ...
10/17/2025 14:20:15

Cantor Fitzgerald analyst Kristen Kluska maintains Disc Medicine (NASDAQ:IRON) with a Overweight and raises the price target...

fda-unveils-first-experimental-drugs-under-fast-track-voucher-plan-to-cut-drug-review-times

FDA Unveils First Experimental Drugs Under...
10/17/2025 14:03:18

The FDA launched a new voucher program to fast-track reviews, naming nine experimental drugs for cancer, diabetes, addiction, a...

Disc Medicine To Present Clinical Data Fro...
10/17/2025 13:04:09

Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commer...

Wedbush Maintains Outperform on Disc Medic...
10/17/2025 12:31:35

Wedbush analyst David Nierengarten maintains Disc Medicine (NASDAQ:IRON) with a Outperform and raises the price target from ...

12 Health Care Stocks Moving In Friday's P...
10/17/2025 12:13:10

Disc Medicine Receives FDA Commissioner's ...
10/16/2025 21:39:03

WATERTOWN, Mass., Oct. 16, 2025 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical compa...

12 Health Care Stocks Moving In Thursday's...
10/16/2025 21:06:04

Disc Medicine Submits New Drug Application...
09/30/2025 12:34:51

Morgan Stanley Maintains Overweight on Dis...
08/18/2025 13:19:54

Morgan Stanley analyst Sean Laaman maintains Disc Medicine (NASDAQ:IRON) with a Overweight and raises the price target from ...

Disc Medicine Q2 EPS $(1.58) Misses $(1.13...
08/07/2025 12:36:14

Disc Medicine (NASDAQ:IRON) reported quarterly losses of $(1.58) per share which missed the analyst consensus estimate of $(1.1...

Truist Securities Initiates Coverage On Di...
07/21/2025 12:10:42

Truist Securities analyst Danielle Brill initiates coverage on Disc Medicine (NASDAQ:IRON) with a Buy rating and announces P...

Disc Medicine Received Feedback From FDA F...
07/21/2025 12:08:17

Morgan Stanley Assumes Disc Medicine at Ov...
07/03/2025 17:41:57

Morgan Stanley analyst Sean Laaman assumes Disc Medicine (NASDAQ:IRON) with a Overweight rating and announces Price Target o...

HC Wainwright & Co. Reiterates Buy on Disc...
07/03/2025 11:16:47

HC Wainwright & Co. analyst Douglas Tsao reiterates Disc Medicine (NASDAQ:IRON) with a Buy and maintains $118 price target.